IMMX

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, California, focused on developing innovative tissue-specific therapies for oncology and inflammatory diseases. The company boasts a robust pipeline of drug candidates designed to address significant unmet medical needs in the U.S. and Australia. With a strong commitment to advanced research and strategic partnerships, Immix is emerging as a pivotal player in the biopharmaceutical sector, with the potential to deliver transformative therapies that could significantly alter current treatment paradigms.